Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith Hintermann

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Cell Science|March 17, 2004
Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblastsMartin Bilban, Nassim Ghaffari-Tabrizi, Edith Hintermann, et al.
JCI Insight|February 27, 2025
The XCL1/XCR1 axis is upregulated in type 1 diabetes and aggravates its pathogenesisCamilla Tondello, Christine Bender, Gregory J Golden, et al.
Molecular Metabolism|July 24, 2025
Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 DiabetesHannah Hipp, Camilla Tondello, Hanna Gmehling, et al.
Frontiers in Physiology|August 25, 2022
Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargementZeynep E Yesilyurt, Jan Matthes, Edith Hintermann, et al.
Journal of Autoimmunity|May 14, 2018
Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in miceEdith Hintermann, Monika Bayer, Clara Benedetta Conti, et al.
Ebiomedicine|June 18, 2024
Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in miceChristian Schmithals, Bianca Kakoschky, Dominic Denk, et al.
ACS Nano|March 19, 2019
Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine ModelMartina Bruna Violatto, Elisabetta Casarin, Laura Talamini, et al.
Theranostics|May 1, 2019
Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse SepsisAndreas von Knethen, Anne Schäfer, Laura Kuchler, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Cell Science|March 17, 2004
Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblastsMartin Bilban, Nassim Ghaffari-Tabrizi, Edith Hintermann, et al.
JCI Insight|February 27, 2025
The XCL1/XCR1 axis is upregulated in type 1 diabetes and aggravates its pathogenesisCamilla Tondello, Christine Bender, Gregory J Golden, et al.
Molecular Metabolism|July 24, 2025
Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 DiabetesHannah Hipp, Camilla Tondello, Hanna Gmehling, et al.
Frontiers in Physiology|August 25, 2022
Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargementZeynep E Yesilyurt, Jan Matthes, Edith Hintermann, et al.
Journal of Autoimmunity|May 14, 2018
Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in miceEdith Hintermann, Monika Bayer, Clara Benedetta Conti, et al.
Ebiomedicine|June 18, 2024
Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in miceChristian Schmithals, Bianca Kakoschky, Dominic Denk, et al.
ACS Nano|March 19, 2019
Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine ModelMartina Bruna Violatto, Elisabetta Casarin, Laura Talamini, et al.
Theranostics|May 1, 2019
Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse SepsisAndreas von Knethen, Anne Schäfer, Laura Kuchler, et al.
Pageof 5